Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 250,000 | 329,000 | 319,000 | 209,300 | 282,800 |
| Marketable Securities | 1,000 | 2,500 | 9,000 | 14,900 | 11,100 |
| Receivables | 1,112,300 | 1,404,900 | 1,330,900 | 1,165,700 | 560,900 |
| Inventories | 984,600 | 1,786,300 | 1,546,500 | 889,400 | 631,000 |
| Income taxes - deferred | 477,000 | 231,800 | 309,300 | 168,100 | 166,700 |
| Other current assets | 3,806,900 | 271,000 | 0 | 0 | 0 |
| TOTAL | $7,110,600 | $4,434,700 | $3,838,300 | $2,569,700 | $1,786,700 |
| Non-Current Assets | |||||
| PPE Net | 283,400 | 1,616,800 | 1,485,000 | 713,700 | 642,300 |
| Investments And Advances | 153,300 | 137,500 | 91,200 | 71,300 | 84,500 |
| Intangibles | 36,988,300 | 16,432,100 | 8,638,500 | 3,321,900 | 3,160,100 |
| Other Non-Current Assets | 8,222,400 | 104,800 | 61,800 | 21,700 | 13,000 |
| TOTAL | $45,647,400 | $18,291,200 | $10,276,500 | $4,128,600 | $3,899,900 |
| Total Assets | $52,758,000 | $22,725,900 | $14,114,800 | $6,698,300 | $5,686,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 534,600 | 176,200 | 184,500 | 0 |
| Accounts payable and accrued liabilities | 3,030,100 | 2,343,200 | 2,467,900 | 1,535,400 | 741,100 |
| Other current liabilities | 2,142,500 | 246,600 | N/A | N/A | N/A |
| TOTAL | $5,247,500 | $3,294,900 | $2,749,300 | $1,839,500 | $808,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,837,700 | 8,517,400 | 6,257,100 | 848,500 | 1,016,100 |
| Deferred Revenues | N/A | 38,800 | 32,300 | 12,800 | 18,900 |
| aiOther Non-Current Liabilities | 1,583,500 | 513,500 | 231,900 | 153,500 | 249,300 |
| TOTAL | $19,175,000 | $9,893,900 | $7,509,100 | $1,296,300 | $1,596,000 |
| Total Liabilities | $24,422,500 | $13,188,800 | $10,258,400 | $3,135,800 | $2,404,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 266,252 | 174,200 | 127,832 | 127,165 | 125,827 |
| Common Shares | N/A | N/A | 400 | 400 | 400 |
| Retained earnings | -198,200 | 1,432,300 | 2,182,700 | 2,085,400 | 1,824,500 |
| Other shareholders' equity | -461,000 | 95,200 | 59,600 | -77,300 | -1,100 |
| TOTAL | $28,335,500 | $9,537,100 | $3,856,400 | $3,562,500 | $3,282,600 |
| Total Liabilities And Equity | $52,758,000 | $22,725,900 | $14,114,800 | $6,698,300 | $5,686,600 |